ASM Global’s Rapidly Expanding Convention Division Unveils Exhibition World Bahrain, Middle East’s Largest Exhibition Centre
23.11.2022 04:57:00 EET | Business Wire | Press release
ASM Global, the world’s leading venue management company and producer of live experiences, has made history with the spectacular firework-laden inauguration ceremony of the 950,000-square-foot Exhibition World Bahrain—the largest exhibition centre in the Middle East.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221122005879/en/
Image courtesy of ASM Global
The Kingdom’s Exhibition World is one of the most contemporary such venues in the world. Its launch is a milestone in the Kingdom’s economic development and is expected to play a key role in advancing the economic competitiveness and positioning of Bahrain as a major global destination for regional and international conventions.
The venue joins ASM Global’s portfolio of more than 350 venues around the world and kicks off the company’s post-pandemic convention growth initiative.
ASM Global’s President and CEO Ron Bension said, “This moment is the culmination of our plan developed during the pandemic leveraging our belief that this part of the world would be the quickest to not only return to normal but move quickly to dramatically increase its convention and exhibition market share.
“We’re also looking forward to leveraging the widest network in the world within the MICE industry to create unique experiences built on years of expertise.”
The opening extravaganza was attended on behalf of His Majesty King Hamad bin Isa Al Khalifa, by His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister of Bahrain.
HRH Prince Salman bin Hamad highlighted the importance of competitiveness as a fundamental element of the kingdom’s economy, which has bolstered investments, promoted economic progress and created quality opportunities for citizens. He also noted that tourism remains a leading economic sector, adding that the sector's growth has been a key driver of the kingdom’s comprehensive development, led by His Majesty the King.
During the ceremony, Bahrain Tourism Minister H.E. Fatima Al Sairafi noted the kingdom’s longstanding history in being a destination linking the east and west for trade, which has furthered its position as a global tourist destination. She added that the inauguration of the venue reflects the kingdom’s commitment to expanding cross-sector development in line with Bahrain's sustainable development goals.
Exhibition World Bahrain is unique for its adaptable and flexible design, featuring 10 halls with a combined total of 95,000 sqm. The spectacular Grand Hall has a capacity of 4,000 seated guests and is supported by 94 meeting rooms as well as 25 F&B and retail outlets throughout the exhibition concourse. The centre’s spacious design enables it to host a number of events simultaneously, making it an attractive location for local, regional and international exhibitions, conventions, galas, weddings, concerts, sports, and live entertainment events.
Exhibition World Bahrain is owned by the Bahrain Tourism and Exhibitions Authority (BTEA), which plans to utilize ASM Global’s wider network within the MICE industry to create unique experiences built on years of expertise.
ASM Global APAC and Gulf Region Chairman and Chief Executive Harvey Lister AM congratulated BTEA on the inauguration of Exhibition World Bahrain, one of the Middle East’s largest exhibition and convention centres.
“ASM Global is proud to be working in partnership with BTEA helping to ensure Bahrain will be at the forefront of attracting tourism investment, international conventions and exhibitions and world-class live events to the Gulf region,” Lister said. “This iconic landmark venue will further position Bahrain as an international destination, helping to drive diversification of growth, benefiting the local economy and further enhancing the kingdom’s global standing.”
Exhibition World Bahrain General Manager Dr Debbie Kristiansen said she was extremely proud of her dedicated and committed team and their passion and determination to “give back” to the beautiful country of Bahrain, helping to create long-term legacies for the future. Dr Kristiansen highlighted the importance of mentoring and building the talent and skillset of young Bahrainis describing it as a “privilege.”
Following the grand opening, Exhibition World Bahrain immediately opened to the public with three concurrent events expected to see well over 100,000 visitors over the span of five days: Jewellery Arabia, the premier jewellery and watch show celebrating its 30th edition; Scent Arabia’s first-ever exhibition; and Cityscape, the region’s largest real estate summit and exhibition.
ASM Global’s network hosts 20,000 events and welcomes 165 million guests every year. Other flagship exhibition and convention centres in its portfolio include McCormick Place in Chicago; Moscone Center in San Francisco; ICC Sydney; Shenzhen World in China; and P&J Live in Aberdeen, U.K.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management—delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centres, and performing arts venues. Follow us on Facebook, Instagram, Twitter and LinkedIn. asmglobal.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005879/en/
Contact information
PRESS CONTACT:
Jim Yeager
jim@breakwhitelight.com (for ASM Global)
Mobile: 818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 14:33:00 EEST | Press release
The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simultaneously building a robust pipeline of next-generation programs in AI-guided neuromodulation and min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 14:24:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: "While the median age of diagnosis for CLL is 70 and the average age of treatment initiation is 75, many pivotal trials still underrepresent the patients that physicians most often see in practice. These data show that the durable benefit of
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 14:00:00 EEST | Press release
Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction. GreensLedge Capital Markets advised the seller. About Clearlake Clearlake Capital is a leading global alternative a
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 14:00:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrated statistical superiority over deucravacitinib for all key secondary endpoints, including PASI 90 response and Static Physician's Global Assessment (sPGA) 0 at week 16. Zasocitinib was generally well tolerated with a consistent safety and tolerability profile and no new safety signals identified. Perspectives on head-to-head zasocitinib study “In this head-to-head study, zasocitinib clearly demonstrated
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 13:30:00 EEST | Press release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reliability, operational efficiency and sustainability performance. The partnership brings together LTTS’ expertise in forward looking technologies and extensive experience ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom